These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 21288837)
1. Implementation of cocooning against pertussis in a high-risk population. Healy CM; Rench MA; Baker CJ Clin Infect Dis; 2011 Jan; 52(2):157-62. PubMed ID: 21288837 [TBL] [Abstract][Full Text] [Related]
2. Pertussis immunization in a high-risk postpartum population. Healy CM; Rench MA; Castagnini LA; Baker CJ Vaccine; 2009 Sep; 27(41):5599-602. PubMed ID: 19647062 [TBL] [Abstract][Full Text] [Related]
3. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Immunization Practices (ACIP), 2011. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(41):1424-6. PubMed ID: 22012116 [TBL] [Abstract][Full Text] [Related]
4. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2011 Jan; 60(1):13-5. PubMed ID: 21228763 [TBL] [Abstract][Full Text] [Related]
5. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Castagnini LA; Healy CM; Rench MA; Wootton SH; Munoz FM; Baker CJ Clin Infect Dis; 2012 Jan; 54(1):78-84. PubMed ID: 22075790 [TBL] [Abstract][Full Text] [Related]
6. Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis. Terranella A; Asay GR; Messonnier ML; Clark TA; Liang JL Pediatrics; 2013 Jun; 131(6):e1748-56. PubMed ID: 23713104 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the impact of a pertussis cocooning program on infant pertussis infection. Healy CM; Rench MA; Wootton SH; Castagnini LA Pediatr Infect Dis J; 2015 Jan; 34(1):22-6. PubMed ID: 24992123 [TBL] [Abstract][Full Text] [Related]
8. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. America Academy of Pediatrics Commitee on Infectious Diseases Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131 [TBL] [Abstract][Full Text] [Related]
9. Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations. Bechini A; Tiscione E; Boccalini S; Levi M; Bonanni P Vaccine; 2012 Jul; 30(35):5179-90. PubMed ID: 22709953 [TBL] [Abstract][Full Text] [Related]
10. Use of mass Tdap vaccination to control an outbreak of pertussis in a high school--Cook County, Illinois, September 2006-January 2007. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2008 Jul; 57(29):796-9. PubMed ID: 18650787 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis. Wei SC; Tatti K; Cushing K; Rosen J; Brown K; Cassiday P; Clark T; Olans R; Pawloski L; Martin M; Tondella ML; Martin SW Clin Infect Dis; 2010 Aug; 51(3):315-21. PubMed ID: 20578875 [TBL] [Abstract][Full Text] [Related]
12. Tetanus and pertussis vaccination coverage among adults aged ≥ 18 years --- United States, 1999 and 2008. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2010 Oct; 59(40):1302-6. PubMed ID: 20948508 [TBL] [Abstract][Full Text] [Related]
13. Cocooning: a concept to protect young children from infectious diseases. Grizas AP; Camenga D; Vázquez M Curr Opin Pediatr; 2012 Feb; 24(1):92-7. PubMed ID: 22157361 [TBL] [Abstract][Full Text] [Related]
14. Kinetics of pertussis immune responses to tetanus-diphtheria-acellular pertussis vaccine in health care personnel: implications for outbreak control. Kirkland KB; Talbot EA; Decker MD; Edwards KM Clin Infect Dis; 2009 Aug; 49(4):584-7. PubMed ID: 19589084 [TBL] [Abstract][Full Text] [Related]
15. Pertussis--United States, 2001-2003. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2005 Dec; 54(50):1283-6. PubMed ID: 16371944 [TBL] [Abstract][Full Text] [Related]
17. Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit. Dylag AM; Shah SI Pediatrics; 2008 Sep; 122(3):e550-5. PubMed ID: 18762489 [TBL] [Abstract][Full Text] [Related]
18. Barriers to early uptake of tetanus, diphtheria and acellular pertussis vaccine (Tdap) among adults-United States, 2005-2007. Miller BL; Kretsinger K; Euler GL; Lu PJ; Ahmed F Vaccine; 2011 May; 29(22):3850-6. PubMed ID: 21459173 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Prenatal Versus Postpartum Tetanus, Diphtheria, and Acellular Pertussis Vaccination in Preventing Infant Pertussis. Winter K; Nickell S; Powell M; Harriman K Clin Infect Dis; 2017 Jan; 64(1):3-8. PubMed ID: 27624955 [TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine. Zepp F; Habermehl P; Knuf M; Mannhardt-Laakman W; Howe B; Friedland LR Vaccine; 2007 Jul; 25(29):5248-52. PubMed ID: 17583395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]